Pamela A. Groben

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Journal: The Journal of investigative dermatology

Published: April 16, 2018

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Journal: JAMA oncology

Published: July 07, 2015

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 03, 2015

Inherited variation at MC1R and histological characteristics of primary melanoma.

Journal: PloS one

Published: November 16, 2014

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Journal: JAMA dermatology

Published: August 28, 2014

Sun exposure and melanoma survival: a GEM study.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: July 30, 2014

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.

Journal: Pigment cell & melanoma research

Published: February 27, 2014

Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society

Published: December 07, 2013

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 16, 2013

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Inherited variation at MC1R and histological characteristics of primary melanoma.

Inherited variation at MC1R and histological characteristics of primary melanoma.

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Sun exposure and melanoma survival: a GEM study.

Sun exposure and melanoma survival: a GEM study.

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.

Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.

Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.

Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.

Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.

Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.

Nontuberculous mycobacterial infection after fractionated CO(2) laser resurfacing.

Nontuberculous mycobacterial infection after fractionated CO(2) laser resurfacing.